Lung Cancer Research Foundation (LCRF) is currently accepting applications for its AstraZeneca Research Award on Strategies Towards Improving the Treatment of Small Cell Lung Cancer 2026. Interested applicants are encouraged to click here to learn more about this opportunity and apply for it.
About LCRF - AstraZeneca Research Award on Strategies Towards Improving the Treatment of Small Cell Lung Cancer
The AstraZeneca Research Award supports innovative research that advances the understanding of Small Cell Lung Cancer (SCLC) and develops new strategies to improve patient outcomes.
SCLC is an aggressive form of lung cancer with limited treatment options and a high rate of disease recurrence. The award encourages translational research that bridges laboratory discoveries with clinical applications to improve diagnosis, treatment, resistance management, and long-term survivorship.
Projects must include research involving SCLC patients and focus on generating findings that can be translated into better clinical care.
Benefits of LCRF - AstraZeneca Research Award on Strategies Towards Improving the Treatment of Small Cell Lung Cancer
The AstraZeneca Research Award provides:
- Maximum funding: US$500,000
LCRF - AstraZeneca Research Award on Strategies Towards Improving the Treatment of Small Cell Lung Cancer Requirements
Applicants must meet the following requirements:
- Be affiliated with a non-profit academic or research institution.
- Be conducting research at a U.S.-based institution.
- Researchers at any career stage are eligible.
- Postdoctoral researchers may apply.
- Clinical fellows may apply.
- Include studies involving Small Cell Lung Cancer patients.
- Include a patient or patient advocate as part of the research team.
- Demonstrate the patient advocate’s involvement in research design.
Application Date and Process
- Click on the link to the application website to apply.
Application Deadline
15 July, 2026
Opportunity Application
View details of
LCRF - AstraZeneca Research Award on Strategies Towards Improving the Treatment of Small Cell Lung Cancer
Apply for LCRF - AstraZeneca Research Award on Strategies Towards Improving the Treatment of Small Cell Lung Cancer
🔍
